NO DETECTABLE RESISTANCE TO BULEVIRTIDE MONOTHERAPY THROUGH 96 WEEKS TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS D

被引：0
|
作者：
Aleman, Soo [1 ]
Liu, Yang [2 ]
Xu, Simin [2 ]
Chang, Silvia [2 ]
Martin, Ross [2 ]
Aeschbacher, Thomas [2 ]
May, Lindsey [2 ]
Manhas, Savrina [2 ]
Han, Dong [2 ]
Yazdi, Tahmineh [2 ]
Martinez, Clarissa [2 ]
Ho, Pui Yan [2 ]
Richards, Christopher [2 ]
Marceau, Caleb [2 ]
Manuilov, Dmitry [2 ]
Flaherty, John F. [2 ]
Maiorova, Evguenia [2 ]
Mo, Hongmei [2 ]
Wedemeyer, Heiner [3 ]
Lampertico, Pietro [4 ]
机构：
[1] Karolinska Inst, Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
[2] Gilead Sci Inc, Foster City, CA 94404 USA
[3] Hannover Med Sch, Hannover, Germany
[4] Univ Milan, Dept Pathophysiol & Transplantat, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1237-C
引用
收藏
页码：S398 / S399
页数：2
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY AT 96 WEEKS OF BULEVIRTIDE 2 MG OR 10 MG MONOTHERAPY FOR CHRONIC HEPATITIS DELTA: RESULTS FROM AN INTERIM ANALYSIS OF A PHASE 3 RANDOMIZED STUDY
    Wedemeyer, Heiner
    Aleman, Soo
    Brunetto, Maurizia R.
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana V.
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Flaherty, John F.
    Osinusi, Anu
    Lau, Audrey H.
    Wiesch, Julian Schulze zur
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    GASTROENTEROLOGY, 2024, 166 (05) : S1600 - S1600
  • [32] Real-world data on treatment with bulevirtide in patients with chronic hepatitis B and D coinfection
    Herta, Toni
    Hahn, Magdalena
    Maier, Melanie
    Niemeyer, Johannes
    Gerhardt, Florian
    Schumacher, Jonas
    Fischer, Janett
    Wiegand, Johannes
    Berg, Thomas
    van Boemmel, Florian
    JOURNAL OF HEPATOLOGY, 2022, 77 : S860 - S860
  • [33] EFFICACY AND SAFETY AT 96 WEEKS OF BULEVIRTIDE 2 MG OR 10 MG MONOTHERAPY FOR CHRONIC HEPATITIS DELTA: RESULTS FROM AN INTERIM ANALYSIS OF A PHASE 3 RANDOMIZED STUDY
    Wedemeyer, Heiner
    Aleman, Soo
    Brunetto, Maurizia
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Flaherty, John
    Osinusi, Anu
    Lau, Audrey
    zur Wiesch, Julian Schulze
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    GUT, 2023, 72 : A103 - A104
  • [34] Efficacy of Bulevirtide in the Treatment of Chronic Hepatitis D Infection: A Systematic Review
    Qirem, Murad
    Yaghi, Shahd
    Jagirdhar, Gowthami Sai Kogilathota
    Okwesili, Byron
    Shamoon, Dema
    Shah, Mehul
    Dacosta, Theodore
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1266 - S1267
  • [35] Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis
    Bogomolov, Pavel O.
    Ivashkin, Vladimir T.
    Bueverov, Alexey O.
    Maev, Igor, V
    Sagalova, Olga, I
    Sleptsova, Snezhana S.
    Yushuk, Nikolay D.
    Gusev, Denis A.
    Zhdanov, Konstantin, V
    Chulanov, Vladimir P.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (11) : 1290 - 1299
  • [36] Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study
    Wedemeyer, Heiner
    Aleman, Soo
    Andreone, Pietro
    Blank, Antje
    Brunetto, Maurizia
    Bogomolov, Pavel
    Chulanov, Vladimir
    Geyvandova, Natalia
    Hilgard, Gudrun
    Mamonova, Nina
    Merle, Uta
    Viacheslav, Morozov
    Sagalova, Olga
    Stepanova, Tatyana
    zur Wiesch, Julian Schulze
    Zotov, Sergey
    Zeuzem, Stefan
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2021, 75 : S294 - S295
  • [37] Efficacy of bulevirtide as monotherapy for chronic hepatitis D (CHD): Week 48 results from an integrated analysis
    Lampertico, P.
    Aleman, S.
    Blank, A.
    Bogomolov, P.
    Chulanov, V.
    Mamonova, N.
    Morozov, V.
    Sagalova, O.
    Stepanova, T.
    Suri, V.
    Manuilov, D.
    Ye, L.
    Flaherty, J. F.
    Osinusi, A.
    Cornberg, M.
    Brunetto, M.
    Wedemeyer, H.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S73 - S73
  • [38] EFFICACY OF BULEVIRTIDE AS MONOTHERAPY FOR CHRONIC HEPATITIS D (CHD): WEEK 48 RESULTS FROM AN INTEGRATED ANALYSIS
    Lampertico, Pietro
    Aleman, Soo
    Blank, Antje
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Suri, Vithika
    Manuilov, Dmitry
    Ye, Lei
    Flaherty, John F.
    Osinusi, Anu O.
    Cornberg, Markus
    Brunetto, Maurizia
    Wedemeyer, Heiner
    HEPATOLOGY, 2022, 76 : S228 - S230
  • [39] BULEVIRTIDE: YES OR NO? TREATMENT FOR HEPATITIS D AND BEYOND
    Xu, Helen Yu
    Yang, Jamie Olivia
    Chen, Phillip
    Han, Steven-Huy B.
    HEPATOLOGY, 2023, 78 : S370 - S371
  • [40] Bulevirtide for chronic hepatitis D: phase III data
    Jordan Hindson
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 559 - 559
12345